Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 24, 2011, Pages 9969-9974

  Finco, Oretta ^a   Frigimelica, Elisabetta ^a   Buricchi, Francesca ^a   Petracca, Roberto ^a   Galli, Giuliano ^a   Faenzi, Elisa ^a   Meoni, Eva ^a   Bonci, Alessandra ^a   Agnusdei, Mauro ^a   Nardelli, Filomena ^a   Bartolini, Erika ^a   Scarselli, Maria ^a   Caproni, Elena ^a   Laera, Donatello ^a   Zedda, Luisanna ^a   Skibinski, David ^a   Giovinazzi, Serena ^a   Bastone, Riccardo ^a   Ianni, Elvira ^a   Cevenini, Roberto ^b   Grandi, Guido ^a   Grifantini, Renata ^a,c   more..

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Externautics SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; B LYMPHOCYTE ANTIGEN; BACTERIAL VACCINE; CD4 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; DRUG DESIGN; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VIVO STUDY; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MICROARRAY; SPLEEN CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; FEMALE; HELA CELLS; HUMANS; IMMUNE SERA; IMMUNIZATION; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; T-LYMPHOCYTES; TH1 CELLS;

CHLAMYDIA; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; MUS;

EID: 79959969499     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1101756108     Document Type: Article

References (51)

1. Igietseme JU, Eko FO, He Q, Black CM (2004) Antibody regulation of Tcell immunity: Implications for vaccine strategies against intracellular pathogens. Expert Rev Vaccines 3:23-34. (Pubitemid 38196953)
2. Kaufmann SH (1997) Antibacterial vaccines: Impact of antigen handling and immune response. J Mol Med 75:360-363.
3. Seder RA, Hill AV (2000) Vaccines against intracellular infections requiring cellular immunity. Nature 406:793-798.
4. Fritzer A, et al. (2010) Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. Infect Immun 78:4051-4067.
5. Pizza M, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816-1820.
6. Rodríguez-Ortega MJ, et al. (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24:191-197. (Pubitemid 43221703)
7. Severin A, et al. (2007) Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins. J Bacteriol 189:1514-1522. (Pubitemid 46446112)
8. Centers for Disease Control and Prevention. Trends in reportable sexually transmitted diseases in the United States (2008) National Surveillance Data for Chlamydia, Gonorrhea and Syphilis (Centers Dis Control, Atlanta), pp 1-7.
9. World Health Organization (2001) Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases. World Health Organization Report 10-13 (WHO, Geneva).
10. Cohen CR, Brunham RC (1999) Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Transm Infect 75:21-24. (Pubitemid 29117476)
11. Paavonen J, Eggert-Kruse W (1999) Chlamydia trachomatis: Impact on human reproduction. Hum Reprod Update 5:433-447. (Pubitemid 29512131)
12. Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE (1992) Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19:185-192.
13. Morrison SG, Su H, Caldwell HD, Morrison RP (2000) Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun 68:6979-6987. (Pubitemid 32463411)
14. Brunham RC, Rey-Ladino J (2005) Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5:149-161. (Pubitemid 40208904)
15. Morrison RP, Caldwell HD (2002) Immunity to murine chlamydial genital infection. Infect Immun 70:2741-2751. (Pubitemid 34564127)
16. Su H, Caldwell HD (1995) CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of themouse genital tract. InfectImmun 63:3302-3308.
17. Rockey DD, Wang J, Lei L, Zhong G (2009) Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines 8:1365-1377.
18. Goodall JC, Yeo G, Huang M, Raggiaschi R, Gaston JS (2001) Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library. Eur J Immunol 31:1513-1522. (Pubitemid 32454699)
19. Coler RN, et al. (2009) Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis. FEMS Immunol Med Microbiol 55:258-270.
20. Follmann F, et al. (2008) Antigenic profiling of a Chlamydia trachomatis gene-expression library. J Infect Dis 197:897-905. (Pubitemid 351417014)
21. Hafner LM, McNeilly C (2008) Vaccines for Chlamydia infections of the female genital tract. Future Microbiol 3:67-77. (Pubitemid 351385952)
22. Meoni E, et al. (2009) CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans. Infect Immun 77:4168-4176.
23. Molina DM, et al. (2010) Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays. Vaccine 28:3014-3024.
24. Olsen AW, et al. (2007) Identification of human T cell targets recognized during Chlamydia trachomatis genital infection. J Infect Dis 196:1546-1552. (Pubitemid 351411992)
25. Sharma J, et al. (2006) Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 74:1490-1499. (Pubitemid 43346781)
26. Wang J, et al. (2009) A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine 27:2967-2980.
27. Hassell AB, Reynolds DJ, Deacon M, Gaston JS, Pearce JH (1993) Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones. Immunology 79:513-519. (Pubitemid 23246885)
28. Roan NR, Starnbach MN (2008) Immune-mediated control of Chlamydia infection. Cell Microbiol 10:9-19. (Pubitemid 350239052)
29. Neidleman JA, Vajdy M, Ugozzoli M, Ott G, O'Hagan D (2000) Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55. Immunology 101:154-160.
30. Ryan EJ, et al. (2000) Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: Distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. J Immunol 165:5750-5759.
31. Darrah PA, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843-850. (Pubitemid 47038186)
32. Grifantini R, Grandi G (2010) New Generation Vaccines, eds Levine MM, Kasper JB, Rappuoli R, Liu M, Good MF (Marcel Dekker, New York-Basel) 737-745.
33. Miyairi I, Ramsey KH, Patton DL (2010) Duration of untreated chlamydial genital infection and factors associated with clearance: Review of animal studies. J Infect Dis 201(Suppl 2):S96-S103.
34. Nelson DE, et al. (2005) Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci USA 102:10658-10663. (Pubitemid 41061610)
35. Igietseme JU, Portis JL, Perry LL (2001) Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun 69:1832-1840. (Pubitemid 32187643)
36. Igietseme JU, et al. (1998) Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun 66:4030-4035. (Pubitemid 28402667)
37. McCluskie MJ, Weeratna RD, Davis HL (2000) Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol Med 6:867-877.
38. Hansen J, et al. (2008) Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model. J Infect Dis 198:758-767.
39. Pal S, Peterson EM, de la Maza LM (2005) Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 73:8153-8160. (Pubitemid 41740303)
40. Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM (2006) Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine 24:766-775. (Pubitemid 43190083)
41. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T (2006) Chlamydial TARP is a bacterial nucleator of actin. Proc Natl Acad Sci USA 103:15599-15604. (Pubitemid 44625638)
42. Dibrov P, Dibrov E, Pierce GN, Galperin MY (2004) Salt in the wound: A possible role of Na+ gradient in chlamydial infection. J Mol Microbiol Biotechnol 8:1-6. (Pubitemid 40468744)
43. DeVinney R, Gauthier A, Abe A, Finlay BB (1999) Enteropathogenic Escherichia coli: A pathogen that inserts its own receptor into host cells. Cell Mol Life Sci 55:961-976. (Pubitemid 29304449)
44. Huston WM, Theodoropoulos C, Mathews SA, Timms P (2008) Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of the extracytoplasmic stress response protease HtrA. BMC Microbiol 8:190-206.
45. Aravind L, Iyer LM, Wellems TE, Miller LH (2003) Plasmodium biology: Genomic gleanings. Cell 115:771-785. (Pubitemid 38058491)
46. Ishino T, Chinzei Y, Yuda M (2005) A Plasmodium sporozoite protein with a membrane attack complex domain is required for breaching the liver sinusoidal cell layer prior to hepatocyte infection. Cell Microbiol 7:199-208. (Pubitemid 40259736)
47. Ponting CP (1999) Chlamydial homologues of the MACPF (MAC/perforin) domain. Curr Biol 9:R911-R913.
48. Dougan G, John V, Palmer S, Mastroeni P (2011) Immunity to salmonellosis. Immunol Rev 240:196-210.
49. Sellge G, et al. (2010) Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J Immunol 184:2076-2085.
50. Smiley ST (2008) Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 7:209-221.
51. Bombaci M, et al. (2009) Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens. PLoS ONE 4:e6332.